Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Long Term Debt 2012–2025
Amphastar Pharmaceuticals Inc. annual long term debt history from 2014 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Amphastar Pharmaceuticals Inc. long term debt as of December 31, 2025: 619.7M, a 1.01% increase year-over-year.
- Amphastar Pharmaceuticals Inc. long term debt for 2025 were 619.7M, a 1.01% increase from 2024.
- Amphastar Pharmaceuticals Inc. long term debt for 2024 were 613.5M, a 1.72% increase from 2023.
- Amphastar Pharmaceuticals Inc. long term debt for 2023 were 603.2M, a 687.00% increase from 2022.
- Amphastar Pharmaceuticals Inc. long term debt for 2022 were 76.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amphastar Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $620 |
| 2024 | $614 |
| 2023 | $603 |
| 2022 | $77 |
| 2021 | $78 |
| 2020 | $46 |
| 2019 | $46 |
| 2018 | $49 |
| 2017 | $46 |
| 2016 | $36 |
| 2015 | $40 |
| 2014 | $43 |
Amphastar Pharmaceuticals Inc. Long Term Debt — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMPH's long term debt history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.